Brandon Miller
On April 29, 2025, Black Hawk Acquisition Corporation (the “Company”) reported the death of Brandon Miller, a member of the Company’s board of directors (the “Board”) and the Chairperson of the Audit Committee.
Highest-materiality recent filing
MVLS fell below $50M for 30 consecutive business days as of March 31, 2026.
Vesicor Therapeutics appoints Michael Tolentino as CEO; Luo Feng becomes CSO
Michael Tolentino, M.D., appointed CEO of Vesicor Therapeutics, the de-SPAC target of Black Hawk Acquisition (Nasdaq: BKHA, BKHAU, BKHAR), effective March 17, 2026.
Black Hawk Acquisition reports ~70% share redemption; $51M withdrawn from trust
Holders of 4,775,923 ordinary shares redeemed at $10.68/share, removing ~$51.0M from trust account.
Black Hawk Acquisition shareholders approve extension to Dec 2026; ~$51M redeemed
Shareholders approved extension of business combination deadline to Dec 22, 2026, with up to 18 monthly extensions at $150k each.
On April 29, 2025, Black Hawk Acquisition Corporation (the “Company”) reported the death of Brandon Miller, a member of the Company’s board of directors (the “Board”) and the Chairperson of the Audit Committee.
Max materiality 0.80 · Median 0.40 · Most common event other_material